α2-adrenoceptors inhibit antidiuretic hormone-stimulated Na+ absorption across tight epithelia (Rana esculenta)

被引:4
作者
Gudme, CN [1 ]
Larsen, AL [1 ]
Nielsen, R [1 ]
机构
[1] Univ Copenhagen, August Krogh Inst, DK-2100 Copenhagen O, Denmark
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2001年 / 442卷 / 03期
关键词
alpha(2)-adrenoceptors; antidiuretic hormone; cAMP; cellular potential; Na+ absorption; noradrenaline; short-circuit current; tight epithelium;
D O I
10.1007/s004240100560
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In the present study we examined the effect of alpha -adrenergic regulation of active transepithelial Na+ absorption across the isolated frog skin epithelium. alpha -Adrenergic stimulation was achieved by addition of the adrenergic agonist noradrenaline in the presence of the beta -adrenergic blocker propranolol. alpha -Adrenergic stimulation inhibited basal as well as antidiuretic hormone (ADH)-stimulated Na+ transport. The ADH-induced increase in Na+ transport was accompanied by a membrane depolarisation due to an increase in the apical Na+ permeability. The subsequent application of noradrenaline inhibited the Na+ transport and repolarised the membrane potential, suggesting that alpha -adrenergic stimulation had reduced the apical Na+ permeability. The inhibition was abolished by the alpha (2)-adrenergic antagonist yohimbine whereas it was insensitive to the alpha (1)-adrenergic antagonist prazosin. alpha -adrenergic stimulation had no effect on the cytosolic free [Ca2+] ([Ca2+](i)). Incubation of the epithelium in the presence of ADH increased the cellular adenosine 3',5'-cyclic monophosphate (cAMP) content, an increase which was abolished by a-adrenergic activation. The effect of alpha -adrenergic stimulation on cAMP production was abolished by the alpha (2)-adrenergic antagonist yohimbine. We conclude that the noradrenaline-induced inhibition of the ADH-stimulated Na+ absorption and cAMP content is mediated by activation of alpha (2)-adrenoceptors. The data further indicate that the principal cells of the epithelium do not express al-adrenoceptors. The noradrenaline-induced inhibition of the ADH-stimulated Na+ transport was concentration dependent, with 0.24 +/-0.03 muM eliciting a half-maximal response. This alpha (2)-adrenergic-mediated down-regulation of Na+ absorption is achieved at a concentration of noradrenaline which begins to activate the NaCl secretion via the skin glands. The alpha (2)-adrenoceptors therefore appear to have considerable physiological importance.
引用
收藏
页码:346 / 352
页数:7
相关论文
共 27 条
[1]   ALPHA-2-AGONISTS BLOCK ADH ACTION IN TOAD BLADDER AND THIS INHIBITION IS NOT MODIFIED BY INDOMETHACIN [J].
ALVO, M ;
ESPINOZA, AM ;
FERNANDEZ, V ;
MARUSIC, ET .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (01) :F74-F77
[2]   PROSTAGLANDIN-E2-STIMULATED GLANDULAR ION AND WATER SECRETION IN ISOLATED FROG-SKIN (RANA-ESCULENTA) [J].
BJERREGAARD, HF ;
NIELSEN, R .
JOURNAL OF MEMBRANE BIOLOGY, 1987, 97 (01) :9-19
[3]   Evidence for P2Y-type ATP receptors on the serosal membrane of frog skin epithelium [J].
Brodin, B ;
Nielsen, R .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (03) :234-239
[4]   An increase in [Ca2+](i) activates basolateral chloride channels and inhibits apical sodium channels in frog skin epithelium [J].
Brodin, B ;
Rytved, KA ;
Nielsen, R .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1996, 433 (1-2) :16-25
[5]   Electrophysiological evidence for an ATP-gated ion channel in the principal cells of the frog skin epithelium [J].
Brodin, B ;
Nielsen, R .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (03) :227-233
[6]  
COTECCHIA S, 1990, J BIOL CHEM, V265, P63
[7]   INHIBITION OF VASOPRESSIN-SENSITIVE CAMP ACCUMULATION BY ALPHA-2-ADRENOCEPTOR AGONISTS IN COLLECTING TUBULES IS SPECIES DEPENDENT [J].
EDWARDS, RM ;
STACK, EJ ;
GELLAI, M ;
BROOKS, DP .
PHARMACOLOGY, 1992, 44 (01) :26-32
[8]   VASOPRESSIN, THEOPHYLLINE, PGE-2 AND INDOMETHACIN ON ACTIVE NA-TRANSPORT IN FROG-SKIN - STUDIES WITH MICROELECTRODES [J].
ELS, WJ ;
HELMAN, SI .
AMERICAN JOURNAL OF PHYSIOLOGY, 1981, 241 (03) :F279-F288
[9]  
Gesek FA, 1996, MOL PHARMACOL, V50, P407
[10]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440